Speakers8th European Beer and Health Symposium
Prof. De Gaetano
Giovanni de Gaetano
MD (Rome), Hematology Specialist (Rome), PhD (Leuven, Belgium), MD (honoris causa) (Debrecen, Hungary and Bialystok, Poland). Director, Department Epidemiology and Prevention, Istituto Neurologico Mediterraneo NEUROMED, Pozzilli.
President, Ethical Committee of Molise Region. President (1997-2007), European Thrombosis Research Organisation (ETRO).
Member, Editorial Board of international journals including European Journal of Nutrition, Nutrition Metabolism and Cardiovascular Diseases.
Chairman of the first EU-funded project on wine and health (FAIR Programme, 1994). Partner of EU-funded projects. Member, Accademia Italiana Vite e Vino. Invited speaker, Pontificia Accademia delle Scienze (Vatican City): “Wine in moderation and health“ and “Bread and Health”. Member, Alcohol in Moderation (AIM) Council. Member, International Scientific Forum on Alcohol Research (Boston University).
Current scientific interest: risk factors for cardio-cerebrovascular disease (MOLI-SANI project). Epidemiology of food, nutrition and health, focus on Mediterranean Diet, wine, beer.
Author of over 500 publications. H index (Top Italian Scientists): 70. Total citations: about 20,000.
Does beer consumption have a place in a healthy lifestyle?
A large evidence-based review on the effects of a moderate consumption of beer on human health has been conducted by an international panel of experts who reached a full consensus on the present document. Low-moderate (up to 1 drink per day in women, up to 2 in men), non-bingeing beer consumption, reduces the risk of cardiovascular disease. This effect is similar to that of wine, at comparable alcohol amounts. Epidemiological studies suggest that moderate consumption of either beer or wine may confer greater cardiovascular protection than spirits. Although specific data on beer are not conclusive, observational studies seem to indicate that low-moderate alcohol consumption is associated with a reduced risk of developing neurodegenerative disease. There is no evidence that beer drinking is different from other types of alcoholic beverages in respect to risk for some cancers. Evidence consistently suggests a J-shaped relationship between alcohol consumption (including beer) and all-cause mortality, with lower risk for moderate alcohol consumers than for abstainers or heavy drinkers. Unless they are at high risk for alcohol-related cancers or alcohol dependency, there is no reason to discourage healthy adults who are already regular light-moderate beer consumers from continuing. Consumption of beer, at any dosage, is not recommended for children, adolescents, pregnant women, individuals at risk to develop alcoholism, those with cardiomyopathy, cardiac arrhythmias, depression, liver and pancreatic diseases, or anyone engaged in actions that require concentration, skill or coordination. In conclusion, although heavy and excessive beer consumption exerts deleterious effects on the human body, with increased disease risks on many organs and is associated to significant social problems such as addiction, accidents, violence and crime, data reported in this document show evidence for no harm of moderate beer consumption for major chronic conditions and some benefit against cardiovascular disease.